sulfonylurea and glp 1 combination Optimizing glycemic control in type 2 diabetes: Clinical outcomes of monotherapy versus combination therapy MD | I'm breaking down

Metformin improves neurobehavioral impairments of streptozotocin-treated and western diet-fed mice: beyond glucose-lowering effects

MDM2, an introduction

In animal stroke models, GLP-1RAs have been associated with various beneficial direct cerebral effects, such as reduced infarct volume, apoptosis, oxidative stress, mitochondrial dysfunction, neuroinflammation, excitotoxicity and BBB permeability, and increased neurogenesis, neuroplasticity, angiogenesis and CBF

These products have not received the safety and quality review of the FDA, and have not adequately been tested on humans like other more rigorously tested products like GLP-1 drugs